Koukourakis, M. I., Giatromanolaki, A., Sivridis, E., Gatter, K. C., Trarbach, T., Folprecht, G., . . . Harris, A. L. (2011). Prognostic and predictive role of lactate dehydrogenase 5 ( LDH5) expression in colorectal cancer patients treated with PTK787/ZK 222584 (Vatalanib) anti-angiogenic therapy.
Citação norma ChicagoKoukourakis, Michael I., et al. Prognostic and Predictive Role of Lactate Dehydrogenase 5 ( LDH5) Expression in Colorectal Cancer Patients Treated With PTK787/ZK 222584 (Vatalanib) Anti-angiogenic Therapy. 2011.
Citação norma MLAKoukourakis, Michael I., et al. Prognostic and Predictive Role of Lactate Dehydrogenase 5 ( LDH5) Expression in Colorectal Cancer Patients Treated With PTK787/ZK 222584 (Vatalanib) Anti-angiogenic Therapy. 2011.